Surgical Resection Combined With Intraperitoneal Hyperthermic Chemotherapy

Hepatocellular Carcinoma Clinical Trial

Official title: A Retrospective Study of Surgical Resection Combined With Intraperitoneal Hyperthermic Chemotherapy in the Treatment of Ruptured Hepatocellular Carcinoma

Status Not yet recruiting

Clinical Trial Summary

Patients with ruptured liver cancer and bleeding after surgical resection were included according to the criteria of admission, and the patients were divided into experimental and control groups. the primary efficacy end point was RFS, and the secondary end point was the rate of abdominal implant metastases and OS.To analyze the efficacy of HIPEC.

Clinical Trial Description

Patients with ruptured liver cancer and bleeding after surgical resection were included according to the criteria of admission, and the patients were divided into groups: experimental group: surgical resection combined with intraperitoneal hyperthermic perfusion chemotherapy, and control group: simple surgical resection. At further follow-up, the primary efficacy end point was time to Recurrence free survival (RFS) ,the time from the patient's treatment until the discovery of abdominal metastases or until the follow-up period, and the secondary end point was the rate of abdominal implant metastases, that is, according to the postoperative follow-up test and imaging findings, the incidence of abdominal implantation and metastasis, until the end of abdominal recurrence or metastasis or observation period. Overall Survival OS and survival rate: the time from the time the patient underwent partial hepatectomy until death from tumor causes or the end of the observation period. To analyze the efficacy of HIPEC. ;

Related Conditions & MeSH terms

• Carcinoma
• Carcinoma, Hepatocellular
• Fever
• Hepatocellular Carcinoma
• Hyperthermia
• Hyperthermic Intraperitoneal Chemotherapy

• NCT number: NCT06247293
• Study type: Observational
• Source: Zhujiang Hospital
• Contact: Mingxin Pan, Prof.
• Phone: 18928918216
• Email: pmxwxy@sohu.com
• Status: Not yet recruiting
• Start date: February 1, 2024
• Completion date: March 31, 2024